SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-003049
Filing Date
2019-12-23
Accepted
2019-12-20 19:24:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13D sc13da207422xom_12202019.htm SC 13D/A 242612
2 EXHIBIT 99.1 - LETTER AGREEMENT, DATED DECEMBER 2, 2019 ex991to13da207422xom_122019.pdf SC 13D/A 127247
  Complete submission text file 0000921895-19-003049.txt   419842
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Subject) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-38028 | Film No.: 191303181
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice